| |
|
|
|
|
|
Improve cost efficiency: High reliability, stability and stand-by function reduce operating costs
Cost-effective analyzer - especially for units running only few tests per day
|
Company:
Date:
December 15, 2008
|
|
|
|
|
|
|
|
|
|
Accurate results in just 70 seconds
Always ready to measure
No manual preparation or calibration prior to measurement
Fast start-up time: Ready within five minutes after replacement of sensor cassette
|
Company:
Date:
December 15, 2008
|
|
|
|
|
|
|
|
|
|
The ACT Plus® System combines a trusted standard in precise clot detection technology with state-of-the-art user enhancements including data management and connectivity-ready capabilities. It is a microprocessor-controlled electromechanical coagulation instrument designed to determine coagulation endpoints in whole blood, and citrated whole blood, samples. Clotting-time results are presented on the instrument’s Clot Time Display (CTD) and Liquid Crystal Display (LCD) screens
|
Company:
Date:
December 16, 2008
|
|
|
|
|
|
|
|
|
|
A two-stage chromogenic assay which measures unfractionated heparin in human plasma by measurement of Factor IIa (thrombin) activity. The inhibitory effect of antithrombin III (ATIII) on Factor IIa (thrombin), Factor Xa and other coagulation serine proteases in plasma is increased several-thousand fold by heparin. This inhibition accounts for the anticoagulant effect of heparin. In the first stage, heparin in the patient sample is allowed to react with ATIII. In the second stage, the heparin–ATIII complex formed inhibits the added thrombin. The residual thrombin hydrolyzes the thrombin-specifi
|
Company:
Date:
December 16, 2008
|
|
|
|
|
|
|
|
|
|
Measures heparin Cofactor II (dermatan sulphate cofactor) in human plasma. The assay is a three stage chromogenic assay using Dermatan Sulfate and excess thrombin. In the first stage, Dermatan sulphate is added to the diluted sample. In the second stage, thrombin is added and inhibition of the thrombin activity occurs. In the third stage, the residual thrombin activity is measured using the thrombin specific chromogenic substrate SPECTROZYME® TH. The heparin Cofactor II concentration is inversely proportional to the residual thrombin concentration.
|
Company:
Date:
December 16, 2008
|
|
|
|
|
|
|
|
|
|
AggRAM™, for platelet aggregation and ristocetin cofactor testing, couples a four-channel analyzer with the power of Windows-based software for unsurpassed testing flexibility. Up to two AggRAM™ modules can be run on one Remote Analyzer Module computer so you can configure your analyzers to suit your testing needs.
|
Company:
Date:
January 04, 2009
|
|
|
|
|
|
|
|
|
|
Helena platelet reagents provide outstanding stability and performance at affordable pricing. Reagents are optimized for use with AggRAM, but may be used on any turbidometric aggregometer of similar quality.
|
Company:
Date:
January 04, 2009
|
|
|
|
|
|
|
|
|
|
The Ristocetin Cofactor assay is more sensitive than RIPA to mild reductions in vWF and more often used to monitor therapy in vWD patients. Kit includes ristocetin, formalinized platelets, S.A.R.P. Reference Plasma, abnormal control and tris-buffered saline for 60 tests.
|
Company:
Date:
January 04, 2009
|
|
|
|
|
|
|
|
|
|
Heparin Venous Blood Vacuum Collection Tubes - Green Tops
|
Company:
Date:
December 28, 2008
|
|
|
|
|
|
|
|
|
|
The aiACT Kit is an in vitro diagnostic reagent for use with the Sonoclot® Coagulation & Platelet Function Analyzer System. The aiACT test is an activated whole blood clotting time test which uses a proprietary blend of celite and other minerals for contact activation. It may also be used with citrated whole blood.
|
Company:
Date:
January 04, 2009
|
|
|
|
|
|